or Try an Advanced Search...

    Technical Analysis for PHIO - Phio Pharmaceuticals Corp.

    Grade Last Price % Change Price Change
    F 2.21 -0.90% -0.02
    PHIO closed down 0.9 percent on Friday, November 15, 2024, on 67 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PHIO trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Older End-of-Day Signals for PHIO ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    New 52 Week Low 1 day ago
    Possible Inside Day 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PHIO Chart by TradingView
    Basic chart:

    Profile

    RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology

    Is PHIO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Phio Pharmaceuticals GAAP EPS of -$1.54
    Nov 14 Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
    Oct 24 Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    Oct 18 Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
    Oct 18 Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series
    Oct 16 Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
    Oct 7 Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells
    Oct 1 Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
    Sep 25 INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
    Sep 16 Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
    See more PHIO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.81
    52 Week Low 2.1678
    Average Volume 75,855
    200-Day Moving Average 5.14
    50-Day Moving Average 3.05
    20-Day Moving Average 2.93
    10-Day Moving Average 2.79
    Average True Range 0.32
    RSI (14) 31.97
    ADX 19.01
    +DI 20.05
    -DI 26.23
    Chandelier Exit (Long, 3 ATRs) 2.75
    Chandelier Exit (Short, 3 ATRs) 3.12
    Upper Bollinger Bands 3.61
    Lower Bollinger Band 2.25
    Percent B (%b) -0.03
    BandWidth 46.44
    MACD Line -0.18
    MACD Signal Line -0.08
    MACD Histogram -0.1016
    Fundamentals Value
    Market Cap 10.11 Million
    Num Shares 4.57 Million
    EPS -7.43
    Price-to-Earnings (P/E) Ratio -0.30
    Price-to-Sales 48.01
    Price-to-Book 0.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.63
    Resistance 3 (R3) 2.67 2.56 2.56
    Resistance 2 (R2) 2.56 2.45 2.54 2.54
    Resistance 1 (R1) 2.38 2.38 2.33 2.35 2.52
    Pivot Point 2.28 2.28 2.25 2.26 2.28
    Support 1 (S1) 2.10 2.17 2.05 2.07 1.90
    Support 2 (S2) 1.99 2.10 1.98 1.88
    Support 3 (S3) 1.82 1.99 1.86
    Support 4 (S4) 1.79